Sandra N. Webb
Direttore/Membro del Consiglio presso Ground Zero Pharmaceuticals Pty Ltd.
Posizioni attive di Sandra N. Webb
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Ground Zero Pharmaceuticals Pty Ltd. | Direttore/Membro del Consiglio | 09/12/2010 | - |
Storia della carriera di Sandra N. Webb
Precedenti posizioni note di Sandra N. Webb
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AVECHO BIOTECHNOLOGY LIMITED | Direttore/Membro del Consiglio | 27/08/2010 | 03/03/2014 |
| Independent Dir/Board Member | 07/03/2012 | 03/03/2014 | |
| ZENYTH THERAPEUTICS LIMITED | Direttore/Membro del Consiglio | - | - |
AusBiotech Ltd.
 AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Direttore/Membro del Consiglio | - | - |
Statistiche
Distribuzione geografica
| Australia | 5 |
Posizioni
| Director/Board Member | 4 |
| Independent Dir/Board Member | 1 |
Settori
| Health Technology | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AVECHO BIOTECHNOLOGY LIMITED | Health Technology |
| Aziende private | 3 |
|---|---|
| Ground Zero Pharmaceuticals Pty Ltd. | |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Commercial Services |
CSL Innovation Pty Ltd.
 CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology CSL Innovation Pty Ltd. develops pharmaceutical products. The firm also develops human antibody inhibitors of the granulocyte-macrophage colony stimulating factor receptor alpha subunit, GM-CSFRa, for potential therapeutic use in inflammatory diseases. The company was founded in 1986 and is headquartered in Richmond, Australia. | Health Technology |
- Borsa valori
- Insiders
- Sandra N. Webb
- Esperienza
